News
A majority of publicly traded US health insurers are expected to post QoQ declines in revenue and net income in Q2. Read more ...
The Cigna Group's fundamentals are solid, but the stock is fairly valued versus peers, not a bargain. Click here to find out ...
HYROX, one of the world's fastest-growing indoor fitness races is set to make a triumphant return to Hong Kong as "Cigna ...
After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $300.0 and $340.0 for Cigna Group, spanning the last three months ...
1d
Zacks Investment Research on MSNWhy Cigna (CI) is a Top Dividend Stock for Your PortfolioWhether it's through stocks, bonds, ETFs, or other types of securities, all investors love seeing their portfolios score big returns. But for income investors, generating consistent cash flow from ...
3d
Barchart on MSNCigna Group's Q2 2025 Earnings: What to ExpectBloomfield, Connecticut-based The Cigna Group (CI) provides insurance and related products and services. Valued at a market ...
With a contract set to expire June 30, the deal with Cigna came down to the wire. Legacy, OHSU execs on ‘catastrophic’ $15B ...
StockStory.org on MSN9d
Why Cigna (CI) Shares Are Sliding TodayShares of health insurance company Cigna (NYSE:CI) fell 3.1% in the afternoon session after the major indices pulled back ...
Cigna sued Bristol Myers Squibb on Tuesday, accusing the drugmaker of violating U.S. antitrust law by keeping generic versions of its blockbuster blood cancer drug Pomalyst off the market so it could ...
Evernorth, which provides pharmacy care and benefits solutions, announced layoffs back in April impacting 62 employees at its ...
Another week, another Adams v. Goliath story in the world of ERISA litigation—and this time, Goliath is Cigna. The company is now facing its ...
It's the latest example of health insurers and health providers taking contract negotiations to the 11th hour.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results